July 10, 2015 (Revised)Separation Agreement • March 29th, 2016 • Global Blood Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 29th, 2016 Company IndustryThis letter confirms our agreement concerning your departure from Global Blood Therapeutics, Inc. (the “Company”). Your last day of employment with the Company will be June 18, 2015 (the “Separation Date”).
GLOBAL BLOOD THERAPEUTICS, INC. FIRST AMENDMENT TO AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • March 29th, 2016 • Global Blood Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 29th, 2016 Company Industry JurisdictionThis First Amendment (the “Amendment”) to Amended and Restated Investors’ Rights Agreement is made and entered into as of January 26, 2016 by and among Global Blood Therapeutics, Inc., a Delaware corporation (the “Company”), and the undersigned Investors. All capitalized terms used herein and not otherwise defined shall have the meanings assigned to them in the Agreement (as defined below).